Department of Materials Engineering, KU Leuven, Kasteelpark Arenberg 44, box 2450, 3001 Leuven, Belgium; Prometheus, Division of Skeletal Tissue Engineering, KU Leuven, Herestraat 49, box 813, 3000 Leuven, Belgium; Skeletal Biology and Engineering Research Center, KU Leuven, Herestraat 49, box 813, 3000 Leuven, Belgium.
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA.
Acta Biomater. 2019 May;90:287-299. doi: 10.1016/j.actbio.2019.03.039. Epub 2019 Mar 21.
For cartilage tissue engineering, several in vitro culture methodologies have displayed potential for the chondrogenic differentiation of mesenchymal stem cells (MSCs). Micromasses, cell aggregates or pellets, and cell sheets are all structures with high cell density that provides for abundant cell-cell interactions, which have been demonstrated to be important for chondrogenesis. Recently, these culture systems have been improved via the incorporation of growth factor releasing components such as degradable microspheres within the structures, further enhancing chondrogenesis. Herein, we incorporated different amounts of gelatin microspheres releasing transforming growth factor β1 (TGF-β1) into micromasses composed of human periosteum derived cells (hPDCs), an MSC-like cell population. The aim of this research was to investigate chondrogenic stimulation by TGF-β1 delivery from these degradable microspheres in comparison to exogenous supplementation with TGF-β1 in the culture medium. Microscopy showed that the gelatin microspheres could be successfully incorporated within hPDC micromasses without interfering with the formation of the structure, while biochemical analysis and histology demonstrated increasing DNA content at week 2 and accumulation of glycosaminoglycan and collagen at weeks 2 and 4. Importantly, similar chondrogenesis was achieved when TGF-β1 was delivered from the microspheres compared to controls with TGF-β1 in the medium. Increasing the amount of growth factor within the micromasses by increasing the amount of microspheres added did not further improve chondrogenesis of the hPDCs. These findings demonstrate the potential of using cytokine releasing, gelatin microspheres to enhance the chondrogenic capabilities of hPDC micromasses as an alternative to supplementation of the culture medium with growth factors. STATEMENT OF SIGNIFICANCE: Gelatin microspheres are utilized for growth factor delivery to enhance chondrogenesis of mesenchymal stem cells (MSCs) in high cell density culture systems. Herein, we employ a new combination of these microspheres with micromasses of human periosteum-derived cells, which possess ease of isolation, excellent expansion potential, and MSC-like differentiation capabilities. The resulting localized delivery of transforming growth factor β1 increases glycosaminoglycan and collagen production within the micromasses without exogenous stimulation in the medium. This unique combination is able to drive chondrogenesis up to similar levels as seen in micromasses that do receive exogenous stimulation. The addition of growth factor releasing microspheres to high cell density micromasses has the potential to reduce costs associated with this strategy for cartilage tissue engineering.
对于软骨组织工程,几种体外培养方法已经显示出了对间充质干细胞(MSCs)软骨分化的潜力。微团、细胞聚集体或微球和细胞片都是细胞密度高的结构,提供了丰富的细胞间相互作用,这对于软骨形成是很重要的。最近,这些培养系统通过在结构中加入生长因子释放成分,如可降解微球,进一步增强了软骨形成。在此,我们将不同量的释放转化生长因子β 1(TGF-β1)的明胶微球掺入由人骨膜来源细胞(hPDC)组成的微团中,hPDC 是一种类似于 MSC 的细胞群体。本研究的目的是研究通过这些可降解微球递送 TGF-β1 对软骨形成的刺激作用,并与在培养基中外源性补充 TGF-β1 进行比较。显微镜观察表明,明胶微球可以成功地掺入 hPDC 微团中,而不会干扰结构的形成,而生化分析和组织学表明,在第 2 周时 DNA 含量增加,在第 2 周和第 4 周时糖胺聚糖和胶原积累增加。重要的是,当通过微球递送 TGF-β1 时,与培养基中添加 TGF-β1 的对照组相比,hPDC 实现了相似的软骨形成。通过增加添加的微球数量来增加微团中的生长因子量,并没有进一步提高 hPDC 的软骨形成能力。这些发现表明,利用细胞因子释放的明胶微球来增强 hPDC 微团的软骨形成能力具有潜力,可以替代在培养基中添加生长因子。 意义声明:明胶微球用于生长因子递送,以增强高细胞密度培养系统中间充质干细胞(MSCs)的软骨形成。在此,我们采用了这些微球与骨膜来源细胞微团的新组合,这些微团具有易于分离、良好的扩增潜力和 MSC 样分化能力。转化生长因子β 1 的局部递送增加了微团中的糖胺聚糖和胶原产生,而无需在培养基中外源刺激。这种独特的组合能够驱动软骨形成,达到与微团中接收到外源性刺激相似的水平。将生长因子释放微球添加到高细胞密度微团中,有可能降低这种软骨组织工程策略相关的成本。